Comparison · NCT02086500-e565cbe9
Prehospital Tranexamic Acid vs Control: Acute Lung Injury
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Prehospital Tranexamic Acid vs Control: Acute Lung Injury. Trial comparisons, record NCT02086500-e565cbe9. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT02086500-e565cbe9
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.094 | 0.0703 | 0.125 | wilson | |
| Risk in group 2 | 0.0861 | 0.0636 | 0.116 | wilson | |
| Risk difference, group 1 minus group 2 | 0.00787 | -0.0299 | 0.0458 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 1.09 | 0.72 | 1.65 | log | |
| Odds ratio, group 1 over group 2 | 1.1 | 0.697 | 1.74 | log | |
| Number needed to treat, for one more participant with the outcome on Prehospital Tranexamic Acid than on Control | 127 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: control.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Prehospital Tranexamic Acid | 1 gram of Tranexamic Acid will be given during emergency medical transport~Tranexamic Acid: 1 gram of prehospital Tranexamic Acid | 42 | 447 | OG000 |
| Group 2 | Control | Identical volume of saline during emergency medical transport~Saline control: Saline Control | 39 | 453 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Acute Lung Injury
- Description
- Time frame
- 7 days
- Population
Source ClinicalTrials.gov
Trial
- Title
- Study of Tranexamic Acid During Air and Ground Medical Prehospital Transport Trial (STAAMP Trial)
- NCT number
- NCT02086500
- Phases
- PHASE3
- Conditions
- Traumatic Hemorrhage
- Interventions
- Tranexamic Acid, Saline control
- Lead sponsor
- Jason Sperry
- Results first posted
- 2020-09-10
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT02086500?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT02086500-e565cbe9